The world deserves early detection
of early detection
Despite immense advances in disease treatment –the timing of diagnosis is still key for successful treatment. The earlier we diagnose disease, the more effective our treatments are.
Today ~50% of all cancers are diagnosed at a late stage.
However most methods for early diseases detection are invasive, unpleasant, expensive, associate with high risk and could cause more harm than good.
Leveraging 10 years of research on nanosensors, NaNose has developed an innovative device for real-time, simple to use, early detection and monitoring of diseases via breath. By combining extensive knowhow on nanomaterials, AI, key engineering and design decisions our DiaNose device based on rapid responding NaNose sensors will be capable of overcoming current barriers to commercial deployment, achieving cost-effectiveness, easy and rapid operation by non-experts, and delivering high clinical sensitivity and specificity.
Nanose Medical – Power of Nanotechnology & Artificial Intelligence –
As Easy As Breathing !
Nanose Medical - fighting lung cancer
Nanose Medical is taking part in LUCIA an international project and consortium supported by the Horizon Europe Program with the mission of improving early detection and management of lung cancer